NEWSMAX @NEWSMAX
Pfizer said on Tuesday its experimental respiratory syncytial virus (RSV) vaccine was found effective for preventing severe infections in infants after being given in a late-stage study to expectant mothers in the second half of pregnancy.https://t.co/u7l3PyQFWs — PolitiTweet.org